VOYAGER Trademark

Trademark Overview

On Monday, July 19, 2021, a trademark application was filed for VOYAGER with the United States Patent and Trademark Office. The USPTO has given the VOYAGER trademark a serial number of 90836176. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, October 18, 2024. This trademark is owned by Vyriad, Inc.. The VOYAGER trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, bio-pharmaceuticals in the nature of oncolytic viruses for the treatment of cancer, excluding gene therapies for neurological diseases and disorders
voyager

General Information

Serial Number90836176
Word MarkVOYAGER
Filing DateMonday, July 19, 2021
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, October 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceuticals, namely, bio-pharmaceuticals in the nature of oncolytic viruses for the treatment of cancer, excluding gene therapies for neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVyriad, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRochester, MN 55901

Trademark Events

Event DateEvent Description
Thursday, July 22, 2021NEW APPLICATION ENTERED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 11, 2022ASSIGNED TO EXAMINER
Monday, April 11, 2022NON-FINAL ACTION WRITTEN
Monday, April 11, 2022NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 28, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 11, 2022SUSPENSION LETTER WRITTEN
Tuesday, October 11, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, October 11, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 11, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 10, 2023SUSPENSION LETTER WRITTEN
Tuesday, October 10, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, October 10, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 17, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, October 18, 2024NON-FINAL ACTION WRITTEN
Friday, October 18, 2024NON-FINAL ACTION E-MAILED
Friday, October 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 10, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 4, 2024ASSIGNED TO EXAMINER

Related Keywords

voyager pharmaceuticals gene therapies neurological disorders diseases excluding cancer namely nature